Large-scale testing (Phase 3)UnknownNCT00779714What this trial is testingComparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTICWho this might be right forMelanoma University of Wuerzburg 360
Testing effectiveness (Phase 2)Study completedNCT00089193What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaWho this might be right forMelanoma (Skin) Craig L Slingluff, Jr
Testing effectiveness (Phase 2)WithdrawnNCT05572463What this trial is testingA Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous MelanomaWho this might be right forUnresectable Cutaneous MelanomaMetastatic Cutaneous Melanoma Innovent Biologics (Suzhou) Co. Ltd.
Early research (Phase 1)Study completedNCT01176474What this trial is testingVaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV MelanomaWho this might be right forMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 73
Not applicableUnknownNCT05171374What this trial is testingPRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicEWho this might be right forMelanoma Stage IIIMelanoma Stage IVMelanoma MelanomaPRO, Russia 500
Testing effectiveness (Phase 2)Study completedNCT00938223What this trial is testingEvaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced MelanomaWho this might be right forMelanoma Craig L Slingluff, Jr 51
Testing effectiveness (Phase 2)Study completedNCT01449279What this trial is testingPilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation TherapyWho this might be right forMelanoma Stanford University 22
Early research (Phase 1)Study completedNCT02680184What this trial is testingClinical Study of CMP-001 in Combination With Pembrolizumab or as a MonotherapyWho this might be right forMelanoma Regeneron Pharmaceuticals 199
Early research (Phase 1)UnknownNCT00003747What this trial is testingCarboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanoma (Skin) Mount Vernon Cancer Centre at Mount Vernon Hospital 30
Early research (Phase 1)UnknownNCT00017355What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Baylor Health Care System
Early research (Phase 1)Study completedNCT01657591What this trial is testingStudy of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV MelanomaWho this might be right forMelanoma H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT03131908What this trial is testingStudy of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN LossWho this might be right forMelanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00031733What this trial is testingVaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) University of Southern California 60
Testing effectiveness (Phase 2)UnknownNCT04749485What this trial is testingHX008 for the Treatment of Patients With Malignant MelanomaWho this might be right forMelanoma Taizhou Hanzhong biomedical co. LTD 119
Early research (Phase 1)Study completedNCT00655655What this trial is testingEverolimus and Vatalanib in Treating Patients With Advanced Solid TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+17 more Mayo Clinic 96
Early research (Phase 1)Study completedNCT00091104What this trial is testingCyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 136
Testing effectiveness (Phase 2)Study completedNCT03200847What this trial is testingPembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaWho this might be right forStage IV MelanomaStage III MelanomaAdvanced Melanoma University of Colorado, Denver 26
Testing effectiveness (Phase 2)UnknownNCT02617849What this trial is testingPembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic MelanomaWho this might be right forMetastatic Malignant Melanoma Wilson Miller 30
Testing effectiveness (Phase 2)Study completedNCT00024011What this trial is testingPS-341 in Treating Patients With Metastatic Malignant MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455What this trial is testingPhase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 MelanomaWho this might be right forMalignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more Rapa Therapeutics LLC 65